rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Nuwellis, Inc.

NUWE · Nasdaq

Health CareMedical DevicesNot moving yet

NUWE stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 96.3% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
5 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders5-3 on the quarter
New · exited2 · 5
Reported value$64K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
SABBY MANAGEMENT, LLCnew · filed 14 Aug 202616,372$50K+16,372
UBS Group AGadded · filed 13 Aug 20264,415$13K+4,369+9497.8%
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026138$421-5,051−97.3%
MORGAN STANLEYnew · filed 13 Aug 202635$107+35
SBI Securities Co., Ltd.reduced · filed 23 Jul 20264$12-59−93.7%
30 Jun 2025 – 30 Jun 2026
1610Jun 25Sep 25Dec 25Mar 26Jun 26

Everyone who traded it

Archelle Georgiou Feldshon Company insiderDirector · last 28 Apr 20260 · 0
David McDonald Company insiderDirector · last 28 Apr 20260 · 0
Gregory D. Waller Company insiderDirector · last 28 Apr 20260 · 1
Martin J. Emerson Company insiderDirector · last 28 Apr 20260 · 0
John L. Erb Company insiderCEO and President · last 27 Jun 20257 · 0
Michael Kendrick McCormick Company insiderDirector · last 20 May 20250 · 0
Robert Benjamin Scott Company insiderChief Financial Officer · last 2 Sep 20230 · 0
Jon W. Salveson Company insiderDirector · last 19 May 20230 · 0
Warren S. Watson Company insiderDirector · last 19 May 20230 · 0
Nestor Jaramillo, Jr. Company insiderPresident and CEO · last 15 Mar 20231 · 0
Neil P. Ayotte Company insiderSVP, Secretary, GC & CCO · last 3 Mar 20230 · 0
Lynn Larson Blake Company insiderChief Financial Officer · last 6 Jan 20230 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202562.0%
Operating profit marginFY 2025 · to 31 Dec 2025-134%
Free cash flow marginFY 2025 · to 31 Dec 2025-132%
Research spendFY 2025 · to 31 Dec 202532.8%
Share count trendFY 2025 · to 6 Mar 202637.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.1M
Free cash flowFY 2025 · to 31 Dec 2025−$10.9M

Analyst forecasts

No analyst forecasts yet.